ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saleem, A
Right arrow Articles by Mohindra, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saleem, A
Right arrow Articles by Mohindra, P
Annals of Clinical and Laboratory Science, Vol 14, Issue 6, 474-479
Copyright © 1984 by Association of Clinical Scientists


Articles

Heparin monitoring during cardiopulmonary bypass

A Saleem, SS Shenaq, DH Yawn, K Harshberger, P Diemunsch, and P Mohindra

Three procedures have been compared for monitoring heparin in patients undergoing cardiopulmonary bypass: (1) activated clotting time (ACT) (2) protamine titration, and (3) fluorometric substrate assay. The ACT monitors the degree of anticoagulation. It is easy to perform and is relatively inexpensive, however, it does not correlate well with heparin levels and may not accurately predict the protamine dose for neutralization of heparin at the completion of bypass. A protamine titration assay or an assay using a thrombin-sensitive fluorometric substrate measures the heparin level and calculates the protamine requirement at the completion of surgery; however, these assays do not indicate the degree of anticoagulation. The fluorometric assay is the less expensive of the two assay measuring heparin, but it requires an experienced technologist to perform the test.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. O. Turner-Gomes, E. P. Nitschmann, G. R. Norman, M. E. Andrew, and W. G. Williams
Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss
Ann. Thorac. Surg., February 1, 1997; 63(2): 482 - 488.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. J. Despotis, J. H. Joist, C. W. Hogue Jr., A. Alsoufiev, K. Kater, L. T. Goodnough, S. A. Santoro, E. Spitznagel, M. Rosenblum, and D. G. Lappas
The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 46 - 54.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. J. Despotis, A. L. Summerfield, J. H. Joist, L. T. Goodnough, S. A. Santoro, E. Spitznagel, J. L. Cox, and D. G. Lappas
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1076 - 1082.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Association of Clinical Scientists.